Descriptions : Beacon Pharmaceuticals PLC is a leading pharmaceutical enterprise in Bangladesh and a pioneer in high-tech specialized drug manufacturing, listed on both the Dhaka Stock Exchange (DSE) and Chittagong Stock Exchange (CSE). Founded in 2006, Beacon gained distinction as the first company in Bangladesh to manufacture complex oncology medicines, biotech products, and active bio-ingredients locally. Operating state-of-the-art WHO-GMP and EU-GMP compliant manufacturing facilities in Bhaluka, Mymensingh, the company produces over 500 formulations spanning critical therapeutic segments. Exporting life-saving oncological and generic drugs to over 130 countries across Asia, Africa, Europe, and Latin America, Beacon Pharmaceuticals plays a vital role in advancing affordable, high-quality specialized healthcare globally.
Ceo Name : Ulfat Karim
Fax Number : +8802222283155
Date of Register : 2006-09-12
Business Type : B2B,B2C
Country : Bangladesh
Goods And Services : Oncology drugs, biopharmaceuticals, generic medicines, cardiovascular treatments, anti-retrovirals, anti-infectives, gastrointestinal medications, central nervous system (CNS) therapies, respiratory formulations, and lyophilized injections.
Isic Code : C210 (Manufacture of pharmaceuticals, medicinal chemical and botanical products)
Affiliated Or Subsidiary Companies : N/A
All monetary figures, including Revenue, Export, Import , and Total Assets, are expressed in Millions of Dollars.
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue:105
Export:0
Import:0
Assets:155
Company Profile | ICCRS - Transparency, Participation, Development.
